IRIS
MINISINI, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.577
NA - Nord America 3.820
AS - Asia 2.859
SA - Sud America 415
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 11.785
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.697
RU - Federazione Russa 1.144
SG - Singapore 944
IE - Irlanda 755
IT - Italia 743
CN - Cina 620
DE - Germania 501
HK - Hong Kong 366
VN - Vietnam 363
BR - Brasile 321
SE - Svezia 320
FR - Francia 316
UA - Ucraina 219
IN - India 191
FI - Finlandia 147
GB - Regno Unito 117
CZ - Repubblica Ceca 94
KR - Corea 77
CA - Canada 71
BD - Bangladesh 62
ID - Indonesia 54
AT - Austria 46
BJ - Benin 44
PL - Polonia 43
TR - Turchia 39
MX - Messico 37
AR - Argentina 35
ES - Italia 33
NL - Olanda 33
IQ - Iraq 24
ZA - Sudafrica 22
BE - Belgio 20
JP - Giappone 19
EC - Ecuador 16
IR - Iran 16
UZ - Uzbekistan 12
VE - Venezuela 11
LT - Lituania 10
CL - Cile 9
EU - Europa 8
PH - Filippine 8
CH - Svizzera 7
CO - Colombia 7
PK - Pakistan 7
PY - Paraguay 7
SA - Arabia Saudita 7
EG - Egitto 6
MA - Marocco 6
PT - Portogallo 6
TN - Tunisia 6
KE - Kenya 5
MD - Moldavia 5
NP - Nepal 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
IL - Israele 4
KZ - Kazakistan 4
PE - Perù 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
HR - Croazia 2
LB - Libano 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 11.779
Salva come PNG Salva come JPEG
Città #
Dublin 743
San Jose 542
Jacksonville 369
Hong Kong 365
Singapore 327
Ashburn 298
Beijing 186
Dearborn 182
Novara 140
Council Bluffs 137
Chandler 132
Moscow 130
Los Angeles 124
Ho Chi Minh City 108
Milan 97
Piemonte 97
Hanoi 93
Lauterbourg 92
Wilmington 87
Lawrence 81
Princeton 81
Munich 79
New York 76
Seoul 68
Ann Arbor 67
Buffalo 66
Turin 60
San Mateo 59
São Paulo 50
Cotonou 44
Santa Clara 42
Frankfurt am Main 41
Jakarta 41
Andover 38
Nuremberg 38
Vercelli 38
Orem 36
Brno 35
Columbus 35
Pardubice 34
Warsaw 34
Denver 31
Dallas 30
Helsinki 30
Brooklyn 29
Chennai 28
London 28
Boardman 25
Falkenstein 24
Amsterdam 23
Houston 22
Bremen 21
Chicago 21
Montreal 21
Atlanta 20
Brussels 20
Nanjing 20
Vienna 20
Toronto 19
Turku 19
Guangzhou 18
Poplar 18
Shanghai 18
Stockholm 18
The Dalles 18
Mexico City 17
Tokyo 17
Düsseldorf 16
Hillsboro 16
Johannesburg 15
Mumbai 14
České Budějovice 14
Rome 13
Phoenix 12
Redondo Beach 12
Biên Hòa 11
Bologna 11
Seattle 11
Boston 10
Dong Ket 10
Hefei 10
Marseille 10
Mülheim 10
Tashkent 10
Tianjin 10
Ankara 9
Brescia 9
Cassano Magnago 9
Charlotte 9
Haiphong 9
Jinan 9
New Delhi 9
Norwalk 9
Ottawa 9
Brasília 8
Da Nang 8
Guayaquil 8
Manchester 8
Stankov 8
West Jordan 8
Totale 6.311
Salva come PNG Salva come JPEG
Nome #
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 230
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 181
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 173
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 169
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 167
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 162
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 159
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 155
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 155
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 153
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 152
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 149
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 148
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 148
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 143
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 142
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 142
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 140
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 140
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 137
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 137
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 136
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 136
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 135
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 135
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 134
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 133
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 132
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 129
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 128
Understanding protection from SARS-CoV-2 using metabolomics 127
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 127
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 124
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 124
Influence of age on sex-related differences among patients with hepatitis C. 123
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 119
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 119
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 119
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 116
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 115
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 115
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 114
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 113
ACE genotype, body weight changes and target organ damage in renal transplant recipients 113
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 110
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 110
Recent advances in HCV entry 110
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 110
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 110
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 109
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 109
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 109
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 108
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 108
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 107
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 106
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 105
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 102
Circadian control of hepatitis B virus replication 102
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 101
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 100
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 100
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 99
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 99
Interferon-stimulated gene pathways in the treatment of viral hepatitis 98
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 95
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 95
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 93
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 92
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 92
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 92
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 91
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 91
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 91
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 90
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 90
Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipose Tissue and Inflammation 88
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 87
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 86
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 85
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 84
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 83
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 83
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 83
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 82
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 82
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 81
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 79
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 79
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 79
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 78
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 77
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 76
From MASH to HCC: the role of Gas6/TAM receptors 75
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 75
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 74
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 73
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 72
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 72
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 71
Totale 11.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.966
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022535 11 23 80 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/20251.687 41 30 91 33 55 91 188 164 341 120 153 380
2025/20265.572 265 215 301 750 607 354 853 900 410 443 323 151
Totale 11.994